Alloy Therapeutics logo

Alloy Therapeutics

North America, Massachusetts, United States, Waltham

Description

Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.

Investor Profile

Alloy Therapeutics has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 5 rounds, about 71% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Corporate Round rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Therapeutics.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (57%)
  • Seed (29%)
  • Corporate Round (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Therapeutics
  • Professional Services
  • Service Industry
  • Medical
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alloy Therapeutics frequently co-invest with?

A
North America, California, United States, Newark
Co-Investments: 2
Presbyterian Health Foundation
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 1
Ampersand Capital Partners
North America, Massachusetts, United States, Wellesley
Co-Investments: 1
Seagull Capital
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1
TH
North America, Florida, United States, West Palm Beach
Co-Investments: 1
Dynamk Capital
North America, New York, United States, New York
Co-Investments: 1
PV
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 1
PR
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 1
Echo Investment Capital
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 4
Charles River Laboratories International
North America, Massachusetts, United States, Wilmington
Co-Investments: 2

What are some of recent deals done by Alloy Therapeutics?

Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics
Series AMar 20, 2025
Amount Raised: $35,000,000
Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics
Series AOct 4, 2022
Amount Raised: $31,000,000
Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical
Series AJun 2, 2022
Amount Raised: $21,000,000
Tegmine Therapeutics

San Francisco, California, United States

Tegmine Therapeutics is a San Francisco-based biotechnology firm.

BiotechnologyProfessional ServicesService Industry
Corporate RoundApr 6, 2022
Mytide Therapeutics

Boston, Massachusetts, United States

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

BiotechnologyHealth CareTherapeutics
Series AMar 8, 2022
Amount Raised: $7,000,000
Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics
SeedJan 4, 2022
Amount Raised: $14,000,000
Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics
SeedJul 21, 2021

Find More Investors Like Alloy Therapeutics

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides